Schuster Katharina, Goelz Rangmar, Speckmann Carsten, Henneke Philipp
From the *Department of Pediatrics and Adolescent Medicine, Medical Center - University of Freiburg, Freiburg, Germany; †Department of Neonatology, University Children's Hospital Tuebingen, 72076 Tuebingen, Germany; and ‡Center for Chronic Immunodeficiency, Medical Center - University of Freiburg, Freiburg, Germany.
Pediatr Infect Dis J. 2017 Feb;36(2):224-227. doi: 10.1097/INF.0000000000001407.
All infants treated with antiviral medication for symptomatic congenital (diagnosis <3 weeks) and probably postnatal (>3 weeks) cytomegalovirus infection were characterized with the help of a survey covering all German Pediatric hospitals between 2012 and 2013. We found that >50% of infants treated for cytomegalovirus were classified as probably postnatal cytomegalovirus infection, which was associated with preterm birth and underlying diseases of the immune system, heart or lung.
2012年至2013年间，通过对德国所有儿科医院的一项调查，对所有接受抗病毒药物治疗的有症状先天性（诊断时间<3周）及可能的产后（>3周）巨细胞病毒感染的婴儿进行了特征描述。我们发现，接受巨细胞病毒治疗的婴儿中，超过50%被归类为可能的产后巨细胞病毒感染，这与早产以及免疫系统、心脏或肺部的基础疾病有关。
